Efficacy of oral tegafur-uracil (UFT) as adjuvant therapy as compared with classical cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in early breast cancer: a pooled analysis of two randomized controlled trials (N.SAS-BC 01 trial and CUBC t
about
Current status of therapy for breast cancer worldwide and in JapanEvidence produced in Japan: tegafur-based preparations for postoperative chemotherapy in breast cancer.Preferences for oral versus intravenous adjuvant chemotherapy among early breast cancer patients.Metronomic Chemotherapy for Primary Non-Metastatic Breast Cancer - a Systematic Review of the Literature.Metronomic chemotherapy for cancer treatment: a decade of clinical studies.Clinical overview of metronomic chemotherapy in breast cancer.Current achievements and future perspectives of metronomic chemotherapy.Antitumor and anticancer stem cell activities of eribulin mesylate and antiestrogens in breast cancer cells.Oral fluoropyrimidine may augment the efficacy of aromatase inhibitor via the down-regulation of estrogen receptor in estrogen-responsive breast cancer xenografts.Orally administered S-1 suppresses circulating endothelial cell counts in metastatic breast cancer patients.Randomized phase II study of anastrozole plus tegafur-uracil as neoadjuvant therapy for ER-positive breast cancer in postmenopausal Japanese women (Neo-ACET BC).The Japanese Breast Cancer Society Clinical Practice Guideline for systemic treatment of breast cancer, 2015 edition.The Japanese Breast Cancer Society Clinical Practice Guideline for systemic treatment of breast cancer.
P2860
Q34983835-872F32AF-CEE5-49E2-8850-258794CE4BD0Q37298361-9FA14BA9-1124-4675-8AE0-B0D331870C45Q37341013-6231FBFF-9EF8-4A67-8617-CB702C7F95E7Q37709874-6EE48DB5-F0EE-44D5-ABC2-813CAF94FDADQ38087885-49B7D078-914D-46D7-8949-A5F3DC54AE5BQ38560651-05181F37-26BF-4AC6-B7DE-17644CA1BBF7Q38788234-2DE39CAD-876F-4CF6-BAC4-651F394356ACQ38924096-7BFAC146-70B6-4644-B9CA-E5D3A71405D8Q39661010-0D383966-8204-4C92-A0B7-D6BC0D487181Q50933865-A96CD093-AA01-49A4-BCD9-323A9555469AQ51749152-B2DF7BD3-EC61-4836-BB95-CAB9E0820A18Q54212765-FB34E679-D1E6-45C6-ADCA-21908873975FQ54324247-03F25C18-F460-4695-9791-74DC5D3F7F8B
P2860
Efficacy of oral tegafur-uracil (UFT) as adjuvant therapy as compared with classical cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in early breast cancer: a pooled analysis of two randomized controlled trials (N.SAS-BC 01 trial and CUBC t
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Efficacy of oral tegafur-uraci ...... (N.SAS-BC 01 trial and CUBC t
@en
Efficacy of oral tegafur-uraci ...... (N.SAS-BC 01 trial and CUBC t
@nl
type
label
Efficacy of oral tegafur-uraci ...... (N.SAS-BC 01 trial and CUBC t
@en
Efficacy of oral tegafur-uraci ...... (N.SAS-BC 01 trial and CUBC t
@nl
prefLabel
Efficacy of oral tegafur-uraci ...... (N.SAS-BC 01 trial and CUBC t
@en
Efficacy of oral tegafur-uraci ...... (N.SAS-BC 01 trial and CUBC t
@nl
P2093
P1476
Efficacy of oral tegafur-uraci ...... (N.SAS-BC 01 trial and CUBC t
@en
P2093
Hideo Inaji
Hiroki Koyama
Muneaki Sano
Takaichiro Suzuki
Toru Watanabe
Yasuo Ohashi
P2888
P304
P356
10.1007/S10549-009-0635-3
P407
P577
2010-02-01T00:00:00Z
P6179
1009896279